日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The Costs of Digital Health Interventions to Improve Immunization Data in Low- and Middle-Income Countries: Multicountry Mixed Methods Study

数字化健康干预措施在改善中低收入国家免疫数据方面的成本：多国混合方法研究

期刊:Journal of Medical Internet Research
影响因子:6
doi:10.2196/62746
Federici, Carlo; Verykiou, Maria; Cavazza, Marianna; Olomi, Willyhelmina; Irakiza, Piero; Kayumba, Kizito; Rodriguez, Edith; Castillo Mendoza, Luis Enrique; Malvolti, Stefano; Hugo, Claire; Ntinginya, Nyanda Elias; Camara, Souleymane; Sabi, Issa; Sano, Nagnouma; Sibomana, Hassan; Condo, Jeanine; Torbica, Aleksandra; Jommi, Claudio; Mantel, Carsten; Mangiaterra, Viviana
免疫/内分泌
发表日期：2025
文献求助 收藏

Horizon scanning and drug expenditure for rare diseases: three-year predictive model in Italy 2025-2027

意大利2025-2027年罕见病药物支出展望及三年预测模型

期刊:Health Economics Review
影响因子:3.3
doi:10.1186/s13561-025-00699-4
Marcellusi, Andrea; Cazzato, Daniela; Guarnotta, Giulio; Aiello, Andrea; Bonfanti, Marzia; Bitonti, Rossella; Guardigni, Melissa; Lucchetti, Chiara; Luccini, Fulvio; Canonico, Pier Luigi; Jommi, Claudio
发表日期：2025
文献求助 收藏

Single-Inhaler Triple Therapy in Primary Care Across Europe: Expert Panel Consensus on the Consequences of Payer-Driven Access Rules and Call to Action

欧洲基层医疗机构单吸入器三联疗法：专家组就支付方主导的准入规则的后果达成共识并呼吁采取行动

期刊:International Journal of Chronic Obstructive Pulmonary Disease
影响因子:3.1
doi:10.2147/COPD.S503726
Di Marco, Fabiano; Shahaj, Orjola; Valipour, Arschang; Legrand, Bertrand; Jommi, Claudio; Micheletto, Claudio; Vogelmeier, Claus Franz; Freeman, Daryl; Kocks, Janwillem W H; Alves, Luis; Rubio, Myriam Calle; Peché, Rudi; Palkonen Snr, Susanna; Winders, Tonya; Roche, Nicolas
发表日期：2025
文献求助 收藏

Obesity in Italy: An Empirical Analysis of Healthcare Consumption, Quality of Life and Comorbidities

意大利的肥胖症：医疗保健消费、生活质量和合并症的实证分析

期刊:Medicina-Lithuania
影响因子:2.4
doi:10.3390/medicina61061061
Brenna, Elenka; Jommi, Claudio
肥胖
代谢
发表日期：2025
文献求助 收藏

Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational study

全面基因组分析和分子肿瘤委员会对治疗成本和个体化治疗可及性的影响：真实世界观察性研究

期刊:BMJ Open
影响因子:2.3
doi:10.1136/bmjopen-2025-099134
De Micheli, Valentina; Agnelli, Luca; Conca, Elena; Rabsiun Aramburu, Victoria Lucia; Baggi, Anna; Vingiani, Andrea; Duca, Matteo; Perrone, Federica; Tamborini, Elena; Piccolo, Alberta; Lorenzini, Daniele; Busico, Adele; Capone, Iolanda; Niger, Monica; Proto, Claudia; Vernieri, Claudio; Manoukian, Siranoush; Gancitano, Giovanni; Ferrario, Matteo; Franzini, Jean Marie; De Braud, Filippo; Pruneri, Giancarlo; Jommi, Claudio
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Paving the road for a successful EU HTA Reform implementation

为欧盟卫生技术评估改革的成功实施铺平道路

期刊:Global & Regional Health Technology Assessment
影响因子:0.5
doi:10.33393/grhta.2025.3502
Severens, Hans; Dillon, Andrew; Meyer, Francois; Jommi, Claudio; Iga, Lipska; Canonico, Pier Luigi; Solà-Morales, Oriol; Altman, Herbert
发表日期：2025
文献求助 收藏

Pivotal Studies for Drugs About to Be Launched for Rare Diseases: Will They Better Support Health Technology Assessment and Market Access than in the Past?

针对即将上市的罕见病药物的关键研究：它们能否比以往更好地支持卫生技术评估和市场准入？

期刊:Journal of Market Access Health Policy
影响因子:
doi:10.3390/jmahp13030037
Jommi, Claudio; Bonfanti, Marzia; Guardigni, Melissa; Aiello, Andrea; Marcellusi, Andrea; Canonico, Pier Luigi; Luccini, Fulvio; Lucchetti, Chiara
发表日期：2025
文献求助 收藏

Shortage of plasma-derived medicinal products: what is next? narrative literature review on its causes and counteracting policies in Italy

血浆衍生药品短缺：下一步是什么？意大利应对措施及原因的叙述性文献综述

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2024.1375891
Bolcato, Matteo; Jommi, Claudio
发表日期：2024
文献求助 收藏

Content validity of the EQ-HWB and EQ-HWB-S in a sample of Italian patients, informal caregivers and members of the general public

在意大利患者、非正式照护者和普通公众样本中，EQ-HWB 和 EQ-HWB-S 的内容效度

期刊:Journal of Patient-Reported Outcomes
影响因子:2.9
doi:10.1186/s41687-024-00706-y
Masutti, Sara; Falivena, Camilla; Purba, Fredrick Dermawan; Jommi, Claudio; Mukuria, Clara; Finch, Aureliano Paolo
发表日期：2024
文献求助 收藏

Correction: From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy

更正：从基于适应症的定价到混合定价模式：意大利价格和报销谈判的证据

期刊:Pharmacoeconomics-Open
影响因子:2.1
doi:10.1007/s41669-024-00475-w
Rossini, Elvio Emanuele; Galeone, Carlotta; Lucchetti, Chiara; Jommi, Claudio
发表日期：2024
文献求助 收藏